Fesoterodine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Fesoterodine and local guidelines before prescribing.

Antimuscarinic

Mechanism

Antimuscarinic.

Uses

Overactive bladder.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Dry mouth, constipation, urinary retention.

Interactions

CYP3A4 and 2D6 inhibitors.

Contraindications and cautions

Urinary retention, glaucoma

Monitoring

Bladder emptying

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Reduce dose in renal and hepatic impairment

Overdose and reversal

Supportive

Special advice

Avoid in cognitively impaired older people.

More from the textbook: uses, cautions and other points
Where it is discussed in the book